These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35272688)

  • 1. Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
    Shinkawa T; Ohuchida K; Mochida Y; Sakihama K; Iwamoto C; Abe T; Ideno N; Mizuuchi Y; Shindo K; Ikenaga N; Moriyama T; Nakata K; Oda Y; Nakamura M
    J Exp Clin Cancer Res; 2022 Mar; 41(1):89. PubMed ID: 35272688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma.
    Gao B; Hu G; Sun B; Li W; Yang H
    J Transl Med; 2024 Oct; 22(1):937. PubMed ID: 39402590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
    Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
    Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment.
    Tao J; Gu Y; Zhang Z; Weng G; Liu Y; Ren J; Shi Y; Qiu J; Wang Y; Su D; Wang R; Fu Y; Liu T; Ye L; Luo W; Chen H; Yang G; Cao Z; Huang H; Xiao J; Ren B; You L; Zhang T; Zhao Y
    J Exp Clin Cancer Res; 2024 Oct; 43(1):277. PubMed ID: 39358777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
    Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
    Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism.
    Li M; Freeman S; Franco-Barraza J; Cai KQ; Kim A; Jin S; Cukierman E; Ye K
    Biomaterials; 2024 Oct; 310():122631. PubMed ID: 38815457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
    Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
    Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles.
    Ali HA; Karasinska JM; Topham JT; Johal D; Kalloger S; Metcalfe A; Warren CS; Miyagi A; Tao LV; Kevorkova M; Chafe SC; McDonald PC; Dedhar S; Parker SJ; Renouf DJ; Schaeffer DF
    Cancer Metab; 2024 Oct; 12(1):28. PubMed ID: 39363341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
    Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
    Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
    [No Abstract]   [Full Text] [Related]  

  • 15. Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.
    Tsujii S; Serada S; Fujimoto M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
    Mol Cancer Ther; 2021 Dec; 20(12):2495-2505. PubMed ID: 34583978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
    Shinkawa T; Ohuchida K; Nakamura M
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system.
    Schuth S; Le Blanc S; Krieger TG; Jabs J; Schenk M; Giese NA; Büchler MW; Eils R; Conrad C; Strobel O
    J Exp Clin Cancer Res; 2022 Oct; 41(1):312. PubMed ID: 36273171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
    Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.